Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OMEROS CORPORATION

(OMER)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 10/26 01:21:34 pm
6.31 USD   -0.16%
10/19OMEROS : HC Wainwright Adjusts Price Target on Omeros to $12 From $19, Maintains Buy Rating
MT
10/18Top Midday Decliners
MT
10/18Omeros Shares Tumble as FDA Turns Away Narsoplimab Application
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Omeros : JPMorgan Starts Omeros at Neutral With $15 Price Target

09/27/2021 | 07:29am EDT


ę MT Newswires 2021
All news about OMEROS CORPORATION
10/19OMEROS : HC Wainwright Adjusts Price Target on Omeros to $12 From $19, Maintains Buy Ratin..
MT
10/18Top Midday Decliners
MT
10/18Omeros Shares Tumble as FDA Turns Away Narsoplimab Application
DJ
10/18Top Premarket Decliners
MT
10/18OMEROS : Receives Complete Response Letter from FDA for Biologics License Application for ..
PU
10/18OMEROS : Says FDA Requires Additional Information on Stem Cell Transplant Therapy Narsopli..
MT
10/18OMEROS CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Other E..
AQ
10/18Omeros Corporation Announces Retirement of Ray Aspiri from the Board of Directors
CI
10/18OMEROS : Receives Complete Response Letter from FDA for Biologics License Application for ..
BU
10/18Omeros Receives Complete Response Letter from FDA for Biologics License Application for..
CI
More news
Analyst Recommendations on OMEROS CORPORATION
More recommendations
Financials (USD)
Sales 2021 108 M - -
Net income 2021 -124 M - -
Net Debt 2021 334 M - -
P/E ratio 2021 -3,28x
Yield 2021 -
Capitalization 395 M 395 M -
EV / Sales 2021 6,74x
EV / Sales 2022 4,88x
Nbr of Employees 277
Free-Float 95,9%
Chart OMEROS CORPORATION
Duration : Period :
Omeros Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OMEROS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 6,32 $
Average target price 18,75 $
Spread / Average Target 197%
EPS Revisions
Managers and Directors
Gregory A. Demopulos Chairman, President & Chief Executive Officer
Michael A. Jacobsen Chief Financial Officer, Treasurer & VP
George A. Gaitanaris Chief Scientific Officer & Vice President-Science
J. Steven Whitaker Chief Medical Officer & Vice President
Thomas J. Cable Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
OMEROS CORPORATION-55.76%395
CSL LIMITED4.38%100 969
WUXI BIOLOGICS (CAYMAN) INC.14.49%64 238
SAMSUNG BIOLOGICS CO.,LTD.6.17%49 692
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.8.14%40 230